Private equity firm acquires Cambridge Major for $212 million

Cambridge Major Laboratories (CML; Germantown, WI), a producer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), and private equity firm American Capital (Bethesda, MD) say that American Capital has invested $212 million to acquire CML. CML was a portfolio company of private equity firm Arlington Capital Partners (Washington) prior to American Capital's investment. American Capital brings significant resources, relationships, and capital to fuel CML's growth, both organically and through acquisition, CML says. “The management...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers